Akanda (AKAN) Non-Current Assets (2020 - 2025)

Akanda's (AKAN) quarterly Non-Current Assets came in at $2.6 million in Q4 2025, down 9.27% year-on-year from $2.9 million in Q4 2024, and down 2.05% quarter-over-quarter from $2.6 million in Q2 2025.

Akanda (AKAN) Non-Current Assets (2020 - 2025) Analysis & Trends

Akanda's Non-Current Assets history runs 6 years deep, the most recent figure standing at $2.6 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 9.27% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $10.5 million, a 77.03% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 9.27% from the prior year.
  • Non-Current Assets retreated to $2.6 million in Q4 2025 per AKAN's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $36.5 million in Q2 2022 and bottomed at $2.4 million in Q2 2024.
  • The 5-year median for Non-Current Assets is $4.1 million (2021), against an average of $14.1 million.
  • Across the five-year window, Non-Current Assets jumped 765.18% in 2022 and tumbled 92.93% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $4.1 million in 2021, then jumped by 765.18% to $35.2 million in 2022, then tumbled by 80.0% to $7.0 million in 2023, then slumped by 59.36% to $2.9 million in 2024, then retreated by 9.27% to $2.6 million in 2025.
  • Per Business Quant, the three latest AKAN Non-Current Assets figures stand at $2.6 million (Q4 2025), $2.6 million (Q2 2025), and $2.9 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Akanda 556,353.85 556,353.85 - 2.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.59 Mn
Jun 30, 2025 2.65 Mn
Dec 31, 2024 2.86 Mn
Jun 30, 2024 2.35 Mn
Dec 31, 2023 7.03 Mn
Jun 30, 2023 33.26 Mn
Dec 31, 2022 35.18 Mn
Jun 30, 2022 36.54 Mn
Dec 31, 2021 4.07 Mn
Dec 31, 2020 4.15 Mn